Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Moll

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Thrombosis Research|February 17, 2015
Whole blood gene expression profiles distinguish clinical phenotypes of venous thromboembolismDeborah A Lewis, Sunil Suchindran, Michele G Beckman, et al.
Blood Advances|May 17, 2023
American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testingSaskia Middeldorp, Robby Nieuwlaat, Lisa Baumann Kreuziger, et al.
Annals of Internal Medicine|January 7, 2015
D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort studyClive Kearon, Frederick A Spencer, Denis O'Keeffe, et al.
The New England Journal of Medicine|February 26, 2003
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolismPaul M Ridker, Samuel Z Goldhaber, Ellie Danielson, et al.
American Heart Journal|April 1, 2009
Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registryEric M Crespo, Gustavo B F Oliveira, Emily F Honeycutt, et al.
Blood|March 2, 2018
Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolismClive Kearon, Sameer Parpia, Frederick A Spencer, et al.
Archives of Internal Medicine|January 16, 2008
Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapyGustavo B F Oliveira, Eric M Crespo, Richard C Becker, et al.
The New England Journal of Medicine|December 7, 2017
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein ThrombosisSuresh Vedantham, Samuel Z Goldhaber, Jim A Julian, et al.
BMJ Open|May 1, 2016
Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocolHolger J Schünemann, Matthew Ventresca, Mark Crowther, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Thrombosis Research|February 17, 2015
Whole blood gene expression profiles distinguish clinical phenotypes of venous thromboembolismDeborah A Lewis, Sunil Suchindran, Michele G Beckman, et al.
Blood Advances|May 17, 2023
American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testingSaskia Middeldorp, Robby Nieuwlaat, Lisa Baumann Kreuziger, et al.
Annals of Internal Medicine|January 7, 2015
D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort studyClive Kearon, Frederick A Spencer, Denis O'Keeffe, et al.
The New England Journal of Medicine|February 26, 2003
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolismPaul M Ridker, Samuel Z Goldhaber, Ellie Danielson, et al.
American Heart Journal|April 1, 2009
Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registryEric M Crespo, Gustavo B F Oliveira, Emily F Honeycutt, et al.
Blood|March 2, 2018
Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolismClive Kearon, Sameer Parpia, Frederick A Spencer, et al.
Archives of Internal Medicine|January 16, 2008
Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapyGustavo B F Oliveira, Eric M Crespo, Richard C Becker, et al.
The New England Journal of Medicine|December 7, 2017
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein ThrombosisSuresh Vedantham, Samuel Z Goldhaber, Jim A Julian, et al.
BMJ Open|May 1, 2016
Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocolHolger J Schünemann, Matthew Ventresca, Mark Crowther, et al.
Pageof 13